Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

December 12, 2019

Primary Completion Date

February 7, 2023

Study Completion Date

February 7, 2023

Conditions
Cognitive Disorders
Interventions
DRUG

MMH-MAP

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (22)

115516

City Clinical Hospital named after V.M. Buyanov, Moscow Department of Health, Moscow

117593

Central Clinical Hospital of the Russian Academy of Sciences, Moscow

150030

Clinical Hospital # 8/Intensive Care Unit, Yaroslavl

163001

The First City Clinical Hospital named after E.E. Volosevich, Arkhangelsk

163045

Arkhangelsk Regional Clinical Hospital/Neurological Department, Arkhangelsk

188643

Vsevolozhsk Clinical Interdistrict Hospital, Vsevolozhsk

192242

St. Petersburg Research Institute of Ambulance named after I.I. Janelidze, Saint Petersburg

194354

City Multidisciplinary Hospital # 2, Saint Petersburg

308007

Belgorod Regional Clinical Hospital of St. Joasaph, Belgorod

350086

Research Institute - Regional Clinical Hospital # 1 named after Prof. S.V. Ochapovsky, Krasnodar

390039

Regional Clinic Hospital/Emergency cardiology unit with intensive care and resuscitation unit, Ryazan

394066

Voronezh Regional Clinical Hospital # 1, Voronezh

410031

Saratov City Clinical Hospital # 9, Saratov

420012

Kazan State Medical University/Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan'

420101

Interregional Clinical Diagnostic Center, Kazan'

420103

City Clinical Hospital # 7, Kazan'

432063

Ulyanovsk Regional Clinical Hospital/Neurological Department, Ulyanovsk

443096

Samara City Clinical Hospital # 1 named after N.I. Pirogov/Neurological Department, Samara

454021

Regional Clinical Hospital # 3, Chelyabinsk

600023

Regional Clinic Hospital/Neurological department for patients with acute cerebrovascular accident, Vladimir

603005

City Clinical Hospital # 5 of the Nizhegorodskiy District of Nizhny Novgorod, Nizhny Novgorod

630087

Novosibirsk State Regional Clinical Hospital, Novosibirsk

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT04295681 - Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders | Biotech Hunter | Biotech Hunter